BioSpace News Archive

Efemoral Medical announced today that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health.

Ocular Therapeutix™ To Present Data at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting.

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Chief Executive Officer of Abeona, will participate in a fireside chat at the Jefferies Cell and Genetic Medicine Summit on Friday, September 30, 2022 at 8:30 a.m. ET.

Regenative Labs, a leading HCT/P manufacturer, has authored a peer-reviewed case study outlining the benefits of dehydrated amniotic membrane allografts (DAMA) in the treatment of advanced venous leg ulcers caused by chronic venous insufficiency (CVI).

Sensorion announces its half-year results as of June 30, 2022, alongside its outlook for the remainder of 2022.

GSK and Spero Therapeutics, Inc. announced they have entered into an exclusive license agreement for Spero’s late-stage antibiotic asset, tebipenem HBr.

Vicore Pharma Holding AB, a clinical-stage pharmaceutical company developing medicines stimulating the angiotensin II type 2 receptor, announces that intra-arterial administration of C21 results in a significant dose-dependent increase in local blood flow.

Inventiva reported its interim financial results for the six months ended June 30, 2022, and provided a corporate update.

Agilis Robotics Limited has announced its fund-raising status, as well as its latest technological achievements.

The 28th annual BIO-Europe is back in person and will take place October 24-26, 2022 in Leipzig, Germany. After being delivered digitally over the last two years, the event is expected to bring together over 4,000 executives from biotech, pharma and finance companies to engage in 27,000+ one-to-one meetings.